These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 7706720

  • 1. Expression of the Fas ligand in cells of T cell lineage.
    Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, Nakao K, Nagata S.
    J Immunol; 1995 Apr 15; 154(8):3806-13. PubMed ID: 7706720
    [Abstract] [Full Text] [Related]

  • 2. Th1 and Th2 subsets equally undergo Fas-dependent and -independent activation-induced cell death.
    Watanabe N, Arase H, Kurasawa K, Iwamoto I, Kayagaki N, Yagita H, Okumura K, Miyatake S, Saito T.
    Eur J Immunol; 1997 Aug 15; 27(8):1858-64. PubMed ID: 9295019
    [Abstract] [Full Text] [Related]

  • 3. IL-2 induces Fas ligand/Fas (CD95L/CD95) cytotoxicity in CD8+ and CD4+ T lymphocyte clones.
    Esser MT, Dinglasan RD, Krishnamurthy B, Gullo CA, Graham MB, Braciale VL.
    J Immunol; 1997 Jun 15; 158(12):5612-8. PubMed ID: 9190908
    [Abstract] [Full Text] [Related]

  • 4. Autocrine and paracrine apoptosis are mediated by differential regulation of Fas ligand activity in two distinct Jurkat T cell populations.
    Su X, Cheng J, Liu W, Liu C, Wang Z, Yang P, Zhou T, Mountz JD.
    J Immunol; 1998 Jun 01; 160(11):5288-93. PubMed ID: 9605126
    [Abstract] [Full Text] [Related]

  • 5. Constitutive Fas ligand expression in several non-lymphoid mouse tissues: implications for immune-protection and cell turnover.
    French LE, Tschopp J.
    Behring Inst Mitt; 1996 Oct 01; (97):156-60. PubMed ID: 8950473
    [Abstract] [Full Text] [Related]

  • 6. Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing.
    Rivoltini L, Radrizzani M, Accornero P, Squarcina P, Chiodoni C, Mazzocchi A, Castelli C, Tarsini P, Viggiano V, Belli F, Colombo MP, Parmiani G.
    J Immunol; 1998 Aug 01; 161(3):1220-30. PubMed ID: 9686582
    [Abstract] [Full Text] [Related]

  • 7. Activation-induced T cell death: resistance or susceptibility correlate with cell surface fas ligand expression and T helper phenotype.
    Oberg HH, Lengl-Janssen B, Kabelitz D, Janssen O.
    Cell Immunol; 1997 Oct 10; 181(1):93-100. PubMed ID: 9344501
    [Abstract] [Full Text] [Related]

  • 8. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
    Shustov A, Nguyen P, Finkelman F, Elkon KB, Via CS.
    J Immunol; 1998 Sep 15; 161(6):2848-55. PubMed ID: 9743345
    [Abstract] [Full Text] [Related]

  • 9. Increased lymphocyte apoptosis in Fas ligand transgenic mice.
    Cheng J, Liu C, Yang P, Zhou T, Mountz JD.
    J Immunol; 1997 Jul 15; 159(2):674-84. PubMed ID: 9218582
    [Abstract] [Full Text] [Related]

  • 10. Cyclosporine-insensitive partial signaling and multiple roles of Ca2+ in Fas ligand-induced lysis.
    Rogers AM, Thilenius AR, Russell JH.
    J Immunol; 1997 Oct 01; 159(7):3140-7. PubMed ID: 9317111
    [Abstract] [Full Text] [Related]

  • 11. Down-modulation of CD4+ T helper type 2 and type 0 cells by T helper type 1 cells via Fas/Fas-ligand interaction.
    Hahn S, Stalder T, Wernli M, Bürgin D, Tschopp J, Nagata S, Erb P.
    Eur J Immunol; 1995 Sep 01; 25(9):2679-85. PubMed ID: 7589145
    [Abstract] [Full Text] [Related]

  • 12. Polarization and apoptosis of T cell subsets in idiopathic thrombocytopenic purpura.
    Chang-Lin WU, Jian-Cheng XU, Fang LI, Hong XI, Xue-Min ZH, Qun CH, Xue-Wen LV.
    Int J Lab Hematol; 2007 Jun 01; 29(3):177-84. PubMed ID: 17474894
    [Abstract] [Full Text] [Related]

  • 13. Interferon-gamma-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells.
    Dao T, Ohashi K, Kayano T, Kurimoto M, Okamura H.
    Cell Immunol; 1996 Nov 01; 173(2):230-5. PubMed ID: 8912881
    [Abstract] [Full Text] [Related]

  • 14. Human colon cancer cells express the functional Fas ligand.
    Ding EX, Hizuta A, Morimoto Y, Tanida T, Hongo T, Ishii T, Yamano T, Fujiwara T, Iwagaki H, Tanaka N.
    Res Commun Mol Pathol Pharmacol; 1998 Jul 01; 101(1):13-24. PubMed ID: 9755840
    [Abstract] [Full Text] [Related]

  • 15. Spontaneous in vivo retrovirus-infected T and B cells, but not dendritic cells, mediate antigen-specific Fas ligand/Fas-dependent apoptosis of anti-retroviral CTL.
    Rich RF, Cook WJ, Green WR.
    Virology; 2006 Mar 15; 346(2):287-300. PubMed ID: 16337984
    [Abstract] [Full Text] [Related]

  • 16. The Fas death pathway controls coordinated expansions of type 1 CD8 and type 2 CD4 T cells in Trypanosoma cruzi infection.
    Guillermo LV, Silva EM, Ribeiro-Gomes FL, De Meis J, Pereira WF, Yagita H, DosReis GA, Lopes MF.
    J Leukoc Biol; 2007 Apr 15; 81(4):942-51. PubMed ID: 17261545
    [Abstract] [Full Text] [Related]

  • 17. Changes in sensitivity of peripheral lymphocytes of autoimmune gld mice to FasL-mediated apoptosis reveal a mechanism for the preferential deletion of CD4-CD8-B220+ T cells.
    Xiao S, Zhang X, Mann KK, Jodo S, Li L, Jarjour WN, Marshak-Rothstein A, Sherr DH, Ju ST.
    Int Immunol; 2004 May 15; 16(5):759-66. PubMed ID: 15096479
    [Abstract] [Full Text] [Related]

  • 18. Expression of Fas ligand mRNA in germinal centres of the human tonsil.
    Kondo E, Yoshino T, Nishiuchi R, Sakuma I, Nishizaki K, Kayagaki N, Yagita H, Akagi T.
    J Pathol; 1997 Sep 15; 183(1):75-9. PubMed ID: 9370951
    [Abstract] [Full Text] [Related]

  • 19. Cutting edge: RANTES regulates Fas ligand expression and killing by HIV-specific CD8 cytotoxic T cells.
    Hadida F, Vieillard V, Mollet L, Clark-Lewis I, Baggiolini M, Debré P.
    J Immunol; 1999 Aug 01; 163(3):1105-9. PubMed ID: 10415001
    [Abstract] [Full Text] [Related]

  • 20. Polarization and apoptosis of T cell subsets in idiopathic thrombocytopenic purpura.
    Liu F, Wu C, Yang X, Xiao H, Zhuo X, Cheng Z, Chen Q.
    Cell Mol Immunol; 2005 Oct 01; 2(5):387-92. PubMed ID: 16368066
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.